Highest Rated Comments


JagerGraf7 karma

Dear Mr. Kersten, Thank you for hosting this Q&A. Can you comment on the company's go-forward plan, and the most recent QC re-submission at ClinicalTrials; had those deficiencies been syntactical in nature?

JagerGraf2 karma

Herr Kersten,

Can you provide any update on the expansion/operations of your cold-fill facility?

Mit freundlichen Grüßen,

Jager

JagerGraf1 karma

Thank you for clarifying!